← FDA Warning Letters

Exela Pharma Sciences LLC

FDA Warning Letter · 2021-04-27 · Office of Pharmaceutical Quality Operations, Division II

Letter

Company
Exela Pharma Sciences LLC
Posted Date
2021-04-27
Letter Issue Date
2021-04-08
Issuing Office
Office of Pharmaceutical Quality Operations, Division II

Subject

Unapproved New Drug/Compounding/Misbranding

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown